Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 41% ± 24% | |
GABAergic neuron | 7 studies | 43% ± 22% | |
interneuron | 6 studies | 41% ± 23% | |
neuron | 4 studies | 23% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 5% | |
GABAergic interneuron | 3 studies | 24% ± 2% | |
granule cell | 3 studies | 21% ± 3% | |
amacrine cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 31% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2829.83 | 2628 / 2642 | 95% | 53.88 | 672 / 705 |
adrenal gland | 11% | 72.18 | 29 / 258 | 67% | 20.81 | 155 / 230 |
pancreas | 2% | 5.30 | 5 / 328 | 24% | 3.37 | 42 / 178 |
tonsil | 0% | 0 | 0 / 0 | 18% | 1.35 | 8 / 45 |
lung | 0% | 0 | 0 / 578 | 10% | 0.98 | 115 / 1155 |
uterus | 0% | 0 | 0 / 170 | 9% | 0.86 | 41 / 459 |
liver | 0% | 0 | 0 / 226 | 7% | 0.67 | 30 / 406 |
intestine | 1% | 1.74 | 5 / 966 | 5% | 0.43 | 26 / 527 |
stomach | 0% | 1.51 | 1 / 359 | 5% | 0.37 | 14 / 286 |
skin | 0% | 0.63 | 3 / 1809 | 4% | 0.81 | 21 / 472 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.47 | 21 / 504 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.19 | 1 / 29 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.42 | 28 / 901 |
breast | 0% | 0 | 0 / 459 | 3% | 0.49 | 33 / 1118 |
eye | 0% | 0 | 0 / 0 | 3% | 0.49 | 2 / 80 |
thymus | 0% | 0.42 | 1 / 653 | 2% | 0.16 | 13 / 605 |
prostate | 0% | 0 | 0 / 245 | 2% | 0.20 | 10 / 502 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.33 | 8 / 430 |
esophagus | 0% | 0 | 0 / 1445 | 2% | 0.13 | 3 / 183 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1905702 | Biological process | regulation of inhibitory synapse assembly |
GO_0007605 | Biological process | sensory perception of sound |
GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0097112 | Biological process | gamma-aminobutyric acid receptor clustering |
GO_0099572 | Cellular component | postsynaptic specialization |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0060077 | Cellular component | inhibitory synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0050811 | Molecular function | GABA receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LHFPL4 |
Protein name | LHFPL tetraspan subfamily member 4 protein (GABAA receptor regulatory Lhfpl4) (Lipoma HMGIC fusion partner-like 4 protein) |
Synonyms | GARLH4 |
Description | FUNCTION: Plays a role in the regulation of inhibitory synapse formation and function by being involved in maintening gamma-aminobutyric acid receptors (GABAARs) clustering and their associated scaffold proteins at inhibitory synaptic sites. Acts in concert with NLGN2 to recruit or stabilize GABAARs. . |
Accessions | Q7Z7J7 ENST00000287585.8 |